Blocking NF-κB Is Essential for the Immunotherapeutic Effect of Recombinant IL18 in Pancreatic Cancer.
Guo X, Zheng L, Jiang J, Zhao Y, Wang X, Shen M, Zhu F, Tian R, Shi C, Xu M, Li X, Peng F, Zhang H, Feng Y, Xie Y, Xu X, Jia W, He R, Xie C, Hu J, Ye D, Wang M, Qin R.
Guo X, et al. Among authors: zheng l.
Clin Cancer Res. 2016 Dec 1;22(23):5939-5950. doi: 10.1158/1078-0432.CCR-15-1144. Epub 2016 Jun 13.
Clin Cancer Res. 2016.
PMID: 27297583